Association between each demographic or healthy lifestyle factor and the use of verified medications among subjects with hypertension recommended/indicated pharmacological treatments (N=11 851): OR was calculated comparing antihypertensive users versus non-users*
| Demographic or healthy lifestyle factors | Adjusted OR (95% CI)‡ | p Value |
| Education >12 years | 1.2 (1.1 to 1.3) | 0.0001 |
| Non-impoverished | 1.2 (1.0 to 1.3) | 0.006 |
| Smoking, Not current | 1.2 (1.1 to 1.3) | 0.002 |
| Alcohol <5 drinks | 1.0 (0.9 to 1.1) | 0.8 |
| Body mass index <25 | 0.7 (0.6 to 0.8) | <0.0001 |
| Moderate physical activity >150 min/week | 1.2 (1.0 to 1.3) | 0.006 |
| Reported health, Excellent/very good | 0.8 (0.7 to 0.9) | <0.0001 |
| Multivitamin use | 1.1 (1.0 to 1.2) | 0.2 |
| Dietary variables | ||
| DASH accordance | 0.9 (0.8 to 1.1) | 0.3 |
| Total fat | 0.9 (0.8 to 1.0) | 0.01 |
| Saturated fat | 1.0 (0.9 to 1.1) | 0.4 |
| Protein | 1.0 (0.9 to 1.1) | 0.5 |
| Fibre | 1.0 (0.9 to 1.1) | 0.6 |
| Cholesterol | 1.0 (0.9 to 1.1) | 0.4 |
| Calcium | 1.1 (1.0 to 1.2) | 0.04 |
| Magnesium | 1.1 (0.9 to 1.2) | 0.4 |
| Potassium | 1.0 (0.9 to 1.1) | 0.8 |
| Sodium | 0.9 (0.8 to 1.0) | 0.02 |
*Users of beta-blockers, thiazide, calcium channel blockers, ACE-I, ARB or any combination of these medications.
†4451 AH users versus7400 non-users.
‡Adjusted for age, gender, race, diabetes, cardiovascular disease (angina, congestive heart failure and cerebrovascular disease) and other comorbid conditions (cancer, arthritis and chronic obstructive pulmonary disease).